Ovid Therapeutics Inc. (OVID)
NASDAQ · Healthcare
Ovid Therapeutics Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 7.3M | 566,000 | 392,000 | 1.5M | 208.4M | 12.6M |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -42.4M | -61.9M | -59.3M | -55.5M | 124.2M | -81.4M |
| EBITDA | -42.2M | -61.3M | -58.7M | -55.0M | 124.4M | -81.1M |
| Net Income | -17.4M | -26.4M | -52.3M | -54.2M | 122.8M | -81.0M |
| Per Share Data | ||||||
| EPS (diluted) | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 130M | 71M | 71M | 70M | 68M | 58M |
Ovid Therapeutics Inc. Income Statement — FAQ
Ovid Therapeutics Inc. (OVID) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see OVID's income statement history?
The chart and table above show Ovid Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.